Who invested in SpringWorks Therapeutics?
SpringWorks Therapeutics's investors include Perceptive Advisors, OrbiMed, Samsara BioCapital, Pfizer and Bain Capital Life Sciences, and 10 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$400Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by FinSMEsSEC filing: $125M sold, first sale Mar 2019
From the SEC filings it signed: 3 on the team.
On the board, as filediCarl L GordonDeval L PatrickFreda L Lewis-HallJeffrey L SchwartzPeter L KeenStephen L Squinto
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
SpringWorks Therapeutics's investors include Perceptive Advisors, OrbiMed, Samsara BioCapital, Pfizer and Bain Capital Life Sciences, and 10 more on record.
SpringWorks Therapeutics has raised $400M across 2 rounds since 2019.
SpringWorks Therapeutics's most recent round was an Undisclosed round of $275M in Dec 2023.
Its most recent round, $275M in Dec 2023, is also its largest on record.
SpringWorks Therapeutics's first round on record, in Apr 2019, was backed by Perceptive Advisors, OrbiMed and Pfizer and 10 others.
SpringWorks Therapeutics's latest named round is an Undisclosed round, in Dec 2023.
SpringWorks Therapeutics is based in the United States.
Perceptive Advisors led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.